Original Source(s)
Related Content
FDA Expands Guselkumab Label in PsA
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
-
2 min
MRI May Define Two Distinct Migraine Phenotypes
Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.
May 21, 2026
-
3 min
Top 10 Clinical Guidance Updates for Physicians
A structured framework of guidelines, consensus statements, therapies, and clinical tools used across practice.
May 19, 2026
-
4 min